Juno Therapeutics Could Nearly Double On Data, Multiple Catalysts, Says FBR Analyst
August 18, 2015 at 09:38 AM EDT
In a report published Tuesday, FBR analyst Ed White initiated coverage of Juno Therapeutics Inc (NASDAQ: JUNO) with an Outperform rating ...